Concordance of epidermal growth factor receptor mutation detection in bodily fluids other than blood with tissue biopsy: A retrospective analysis-Reference-Cited by-同舟云学术

Concordance of epidermal growth factor receptor mutation detection in bodily fluids other than blood with tissue biopsy: A retrospective analysis

Published:2020 Issue:3 Volume:3 Page:475
ISSN:2590-3233
Container-title:Cancer Research, Statistics, and Treatment
language:en
Short-container-title:Cancer Res Stat Treat

Author:

Chougule Anuradha,Pange Priyanka,Kale Shrutika,Jagtap Vinita,Nambiar Kavya,Nikam Ankita,Tiwrekar Priyanka,Trivedi Vaishakhi,Behel Vichitra,Kapoor Akhil,Menon Nandini,Patil Vijay,Noronha Vanita,Prabhash Kumar,Banavali SD

Publisher

Medknow

Subject

General Medicine

Reference18 articles.

1. Epidermal growth factor receptor-mutated non-smallcell lung cancer: A primer on contemporary management;Rajendra;Cancer Res Stat Treat,2019

2. Frequency of EGFR mutations in 907 lung adenocarcioma patients of Indian ethnicity;Chougule;PLoS One,2013

3. Epidermal growth factor receptor tyrosine kinase inhibitor-resistant disease;Ohashi;J Clin Oncol,2013

4. Genotypic and histological evolution of lung cancers acquiring resistance to EGFR inhibitors;Sequist;Sci Transl Med,2011

5. EGFR mutation and resistance of non-small-cell lung cancer to gefitinib;Kobayashi;N Engl J Med,2005

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A personalized approach to the management of rare genetic aberrations in oncology: A letter citing the EGFR exon 18 mutation molecular tumor board report;Cancer Research, Statistics, and Treatment;2024-01

2. A narrative review of the role of common EGFR mutations in pathogenesis and treatment of non-small-cell lung carcinoma;Cancer Research, Statistics, and Treatment;2022-07

3. Circulating tumor DNA in non-small-cell lung cancer: A step beyond blood;Cancer Research, Statistics, and Treatment;2020